MARKET

STAA

STAA

Staar Surg
NASDAQ
22.29
+0.44
+1.99%
After Hours: 22.29 0 0.00% 16:20 01/17 EST
OPEN
22.49
PREV CLOSE
21.86
HIGH
22.62
LOW
22.14
VOLUME
490.91K
TURNOVER
--
52 WEEK HIGH
52.68
52 WEEK LOW
21.13
MARKET CAP
1.10B
P/E (TTM)
50.88
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at STAA last week (0113-0117)?
Weekly Report · 5h ago
Staar Surgical is Now Oversold (STAA)
NASDAQ · 5d ago
Staar Surgical: Strategic Resilience and Long-Term Growth Potential Amidst Competitive Pressures
TipRanks · 6d ago
Staar Surgical to Announce 2024 Financial Results
TipRanks · 01/13 13:02
Press Release: STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025
Dow Jones · 01/13 12:15
Weekly Report: what happened at STAA last week (0106-0110)?
Weekly Report · 01/13 09:45
Staar Surgical: Hold Rating Amid Competitive Pressures and Strategic Initiatives
TipRanks · 01/08 12:06
ProDex (PDEX) Moves 23.0% Higher: Will This Strength Last?
NASDAQ · 01/07 12:12
More
About STAA
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.

Webull offers STAAR Surgical Co stock information, including NASDAQ: STAA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STAA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STAA stock methods without spending real money on the virtual paper trading platform.